The Maryland Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Maryland Observer.

Press releases published on August 3, 2026

Aug. 3, 2026

Airtripmaker Enhances Access to Flights to India from USA for Travelers seeking Economy and Business Class air tickets

Indeterminate EIN Presswire

Aug. 3, 2026

Spartan Medical Strengthens Commitment to American-Made PPE Through AMMA Membership

Indeterminate EIN Presswire

Aug. 3, 2026

Usalco Appoints Water Technology Entrepreneur Megan Glover as Chief Digital Officer

Indeterminate EIN Presswire

Aug. 3, 2026

Everyone Still Thinks Tesla Is a Car Company. Legendary Tech Expert Says That’s the Mistake of the Decade

Indeterminate GlobeNewswire

Aug. 3, 2026

Collaborative Shared Technologies LLC® Expands AI, Knowledge Management, Microsoft, and GovCon Capabilities

Indeterminate EIN Presswire

Aug. 3, 2026

Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

InventWood Selected for DARPA Embedded Entrepreneur Initiative to Accelerate SUPERWOOD’s Transition into Defense and Dual-Use Markets

Indeterminate GlobeNewswire

Aug. 3, 2026

James Altucher Says Elon Musk’s Next Move Could Unleash $25 Trillion, More Than China, Russia, and England Combined

Indeterminate GlobeNewswire

Aug. 3, 2026

Jim Rickards Says a Single "Magic Trick" Is Propping Up AI, the Same One That Sank Telecom in 2000.

Indeterminate GlobeNewswire

Aug. 3, 2026

TOMI Environmental Solutions Receives EPA Registration Expanding SteraMist® for Use in Post-Harvest Agricultural Food Safety Including Cannabis and Hemp Cultivation

Indeterminate GlobeNewswire

Aug. 3, 2026

A Crash This Time Could Erase More Value Than the Entire U.S. Economy Produces in a Year.

Indeterminate GlobeNewswire

Aug. 3, 2026

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

Indeterminate GlobeNewswire

Aug. 3, 2026

Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors

Indeterminate GlobeNewswire

Aug. 3, 2026

X-energy, SGL Carbon Announce Capacity Expansion for Nuclear-Grade Graphite

Indeterminate GlobeNewswire

Aug. 3, 2026

Supernus Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Indeterminate GlobeNewswire

Aug. 3, 2026

Hughes Files Chapter 11 Voluntary Reorganization to Strengthen Capital Structure and Evolve Business to Meet Market Demand

Indeterminate GlobeNewswire